ArticleEJNMMI physics2025
Article in EJNMMI physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- From sensitivity gain to clinical decisions: total-body and long-axial-field-of-view PET/CT for diagnosis and image-based management in oncology and systemic disease.Annals of nuclear medicine · 2026Review
- How can children benefit from total-body PET?The British journal of radiology · 2026Review
- The Impact of PET Imaging on Translational Medicine: Insights from Large-Animal Disease Models.Biomolecules · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeTo explore the feasibility of reducing scan duration of
methodsForty-five patients with known or suspected coronary artery disease (CAD) performing rest
resultsThere were no significant differences in subjective visual scores between G7-G5 and G10 groups (p > 0.05). A significant decrease in overall impression and image noise of G3-G2 was observed when compared to G10 (p < 0.05). However, no significant difference in lesion visibility was noted between G3 and G10 (p > 0.05). All G3 image quality was clinically acceptable (≥ 3 points). Except for EDV and ESV, other quantitative parameters showed no significant difference between G7-G3 and G10 (p > 0.05) and agreements were good (ICC = 0.974-0.998). For G2, only TPD exhibited no significant difference when compared to G10 (p > 0.05).
conclusionRegarding imaging quality and parametric quantification accuracy of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.